The Business Research Company published its Genito-Urinary Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Genito-Urinary Drugs market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers
the Genito-Urinary Drugs market’s segments-
1) By Type,
Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For
Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And
Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal
Replacement Therapy, Diuretics
2) By
Distribution Channel, Hospital Pharmacies, Retail Pharmacies/ Drug Stores,
Others
3) By Route Of
Administration, Oral, Parenteral, Others
4) By Drug
Classification, Branded Drugs, Generic Drugs
5) By Mode Of
Purchase, Prescription-Based Drugs, Over-The-Counter Drugs.
View Complete Report:
Genito-Urinary Drugs Global Market Report
2020 is the most comprehensive report available on this market and will help
gain a truly global perspective
as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable
insights on supply chain disruptions, logistical challenges, and other economic
implications of the virus on the market. The chapter also covers markets which
have been positively affected by the pandemic.
The global genito-urinary drugs market is
expected to decline from $54.2 billion in 2019 to $43.8 billion in 2020 at a
compound annual growth rate (CAGR) of -19.3%. The decline is mainly due to the
disruption caused by the lockdown measure across various countries to contain
COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly
as people are staying at home and are less likely to get exposed to factors
that might cause genito-urinary infections, or other hormonal diseases caused
by lifestyle changes or eating habits. The market is then expected to recover
and grow at a CAGR of 4% from 2021 and reach $61.4 billion in 2023.
The launch of combination products for the
treatment of urinary tract infections is an emerging trend in the
genito-urinary disorder drugs market. Competitors in the market are developing
combination drugs to fight multi-drug resistant bacteria and also expanding
indications for existing drugs for the treatment of genito-urinary disorders.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Genito-Urinary Drugs Market Characteristics
4. Genito-Urinary Drugs Market Product Analysis
5. Genito-Urinary Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market
21. Market
Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
Table 1:
Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Genito-Urinary Drugs Market, 2019,
By Region, Value ($ Billion)
Table 4: Global Genito-Urinary Drugs Market,
2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 5: Global Genito-Urinary Drugs Market, Growth
And Market Share Comparison, By Region ……..
Table 114:
Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic
And Forecast, By Region
Table 115: Global Pharmaceutical Drugs Market,
2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 116: Global Genito-Urinary Drugs Market In
2023- Growth Countries
Table 117: Global Genito-Urinary Drugs Market In
2023- Growth Segments
Table 118: Global Genito-Urinary Drugs Market In
2023- Growth Strategies
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment